Valganciclovir
Brand name: Valcyte
Valganciclovir comes in 11 pill versions in our database, in 1 strength, from 11 manufacturers. Check the imprint to tell them apart.
Valganciclovir pill images
450 mg 11 pills
-
RDY 762
Valganciclovir 450 mg
Pink, oval, 17 mm
Used for aids-related opportunistic infections and cytomegalovirus retinitis
- RDY 762 Valganciclovir Hydrochloride 450 mg Pink, capsule, 16 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- E114 Valganciclovir Hydrochloride 450 mg Pink, oval, 17 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- J 156 Valganciclovir 450 mg Pink, oval, 17 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- VGC 450 Valganciclovir 450 mg Pink, oval, 17 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- VL 450 Valganciclovir 450 mg Pink, oval, 17 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- H 96 Valganciclovir Hydrochloride 450 mg Pink, oval, 17 mm Used for aids-related opportunistic infections and cytomegalovirus retinitis
- 93 5465 Valganciclovir Hydrochloride 450 mg Pink, oval Used for aids-related opportunistic infections and cytomegalovirus retinitis
- H 96 Valganciclovir Hydrochloride 450 mg Pink, oval Used for aids-related opportunistic infections and cytomegalovirus retinitis
- J 156 Valganciclovir Hydrochloride 450 mg Pink, oval Used for aids-related opportunistic infections and cytomegalovirus retinitis
- No picture yet DIN 02245777 Valganciclovir Hydrochloride 450 mg Valcyte, Tablet, sold in Canada Used for aids-related opportunistic infections and cytomegalovirus retinitis
What is Valganciclovir used for?
Valganciclovir is used for aids-related opportunistic infections and cytomegalovirus retinitis.
- Medicine type
- Antiviral
Official uses from the US prescribing label
Adult Patients
Treatment of Cytomegalovirus (CMV) Retinitis: Valganciclovir Tablets are indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).
Prevention of CMV Disease: Valganciclovir Tablets are indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-]).
Pediatric Patients
Prevention of CMV Disease: Valganciclovir Tablets are indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk.
From the FDA-approved label on DailyMed (published Jun 08, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.